Results 111 to 120 of about 5,014,769 (257)

The V2 order in the history of European Spanish and Portuguese

open access: yesFilologia e Linguística Portuguesa, 2014
We approach the loss of the V2 effect in the history of Spanish and European Portuguese. In this context, we discuss what we understand as Verb Second, assuming that the V2 order involves verb movement to CP.
Carlos Felipe Pinto   +1 more
doaj   +1 more source

Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry

open access: yesArthritis &Rheumatology, EarlyView.
Objective Cancer represents a major cause of death in systemic sclerosis (SSc). Established risk factors are limited to specific subsets, particularly early diffuse anti‐RNA polymerase III (POLR3)–positive disease, needing further exploration. Methods We performed a nested case‐control study within the European Scleroderma Trials and Research group ...
Antonio Tonutti   +52 more
wiley   +1 more source

Third person accusative and dative clitics

open access: yesIsogloss
This article shows a contrastive analysis of 3rd person accusative and dative clitics and their variant forms in spoken Brazilian, Mozambican and Santomean varieties of Portuguese as compared with European Portuguese.
Maria Eugenia Lammoglia Duarte   +2 more
doaj   +1 more source

Late acquisition of pronoun use in European Portuguese: Subject–object asymmetries in Portuguese-German bilingual children

open access: yes
This study investigates the use of subject and object pronouns in European Portuguese (EP) by Portuguese–German bilingual children living in Switzerland and their monolingual peers in Portugal. Written narratives from 61 children aged 10–12 were analysed
Cristina Flores   +3 more
core   +1 more source

Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Real‐world initial treatment strategies in systemic sclerosis–associated pulmonary arterial hypertension (SSc‐PAH) remain incompletely described. We aimed to characterize these strategies across hemodynamic thresholds and risk strata and evaluate outcome associations. Methods We analyzed treatment‐naive patients with SSc‐PAH from the European
Hilde Jenssen Bjørkekjær   +63 more
wiley   +1 more source

Regional Convergence in Portugal: Policy Impacts (1990-2001) [PDF]

open access: yes
In this study we look at whether the seven Portuguese NUTS II regions have been able to share equally in the country’s overall growth or whether there have been asymmetries and divergences in their growth patterns. We assess the regional impact of a wide
Annette Bongardt   +5 more
core  

'Still the Century of Corporatism?' Corporatism in Southern Europe. Spain and Portugal in Comparative Perspective, CES Working Paper, no.75 [PDF]

open access: yes, 2001
This paper analyzes the resurgence of national-level social bargaining in two European states: Portugal and Spain. It argues that this development derives from the combination of two main factors: the weakening of trade union organizations at the branch ...
Royo, Sebastian.
core  

The portuguese natural gas market in the european context [PDF]

open access: yes, 2004
The Portuguese natural gas market is recent and small – being an emergent market according to Directive 98/30/EC. It is still protected and monopolistic while most other European countries have already liberalized, at least partially, their natural gas ...
Ferreira, Paula Varandas   +2 more
core   +1 more source

Sema4A neutralization reduces fibrosis and inflammation in a mouse model of systemic sclerosis and a 3D model of immunity‐driven fibrosis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective We previously showed that Semaphorin4A (Sema4A) is elevated in patients with systemic sclerosis (SSc) and promotes inflammation and fibrosis in vitro. Here, we examined the effect of Sema4A neutralization in vivo and in 3D fibrosis models. Methods Sema4A plasma levels were measured by ELISA in healthy controls (n=31) and patients with SSc (n=
Jaime Marty   +21 more
wiley   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Home - About - Disclaimer - Privacy